Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • New for 2026! CCAS QI/Education Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

Question of the Week 470

Authors: Greesha S. Pednekar, MD - Children’s Memorial Hermann Hospital, University of Texas Health Science Center at Houston, TX and Destiny F. Chau, MD - Arkansas Children’s Hospital /University of Arkansas for Medical Sciences, Little Rock, AR


A 2-year-old girl with a history of dilated cardiomyopathy and subsequent left ventricular assist device implantation has persistent right ventricular failure supported with high doses of inotropic medications and inhaled nitric oxide. According to the Pedimacs registry, which of the following percentages MOST accurately reflects the approximate rate of right ventricular failure in the first month after left ventricular assist device placement?

Correct! Wrong!

EXPLANATION


Patients undergoing left ventricular assist device (LVAD) placement are at risk of right ventricular (RV) failure. Persistent RV failure is associated with increased morbidity and mortality, including multi-organ dysfunction, which may jeopardize transplant candidacy. Anticipation, prevention, and early detection of RV failure is imperative in LVAD planning and management.


An analysis of the largest pediatric VAD registry, called the Pedimacs registry, by Simpson et al demonstrated that 55% of children had RV failure during a time frame between one week to one month after LVAD implantation. An additional 25% of pediatric patients had RV failure between one and three months after LVAD placement. Factors associated with RV failure were younger age, lower weight, INTERMACS profile 1, chemical paralysis, and a pulsatile flow device. In addition, RV failure was associated with an increased risk of death during device support at time points of greater than one month (hazard ratio 3.2, 95% CI 1.4-7.7, p = 0.007) and greater than three months after LVAD insertion (hazard ratio 6.9, 95% CI 2-23.1, p = 0.002). In this analysis, RV failure was defined as prolonged inotrope use or subsequent need for right VAD.


Deterioration of RV function after LVAD implantation can occur due to a number of reasons, including the following:1) Increased cardiac output results in increased systemic venous return and acute increases in RV preload, myofibril stretch, wall tension and myocardial oxygen demand, which may not be well tolerated under circumstances of depressed RV function; 2) LV unloading causes a leftward shift of the interventricular septum, thereby distorting RV geometry and interfering with the RV free wall contractility and worsening tricuspid regurgitation; 3) Apical LVAD implantation can impede the normal twisting motion of the RV, thereby impeding RV contractility and; 4) Intraoperative myocardial ischemia may further worsen RV function.


After LVAD placement, anticipation of and preparation for RV failure during separation from cardiopulmonary bypass is critically important. Support of the RV includes initiation of inhaled nitric oxide, inotropic support, and avoidance of RV distension by excessive volume administration, along with avoidance of hypoxia and hypercarbia. Transesophageal echocardiography may be utilized to assess ventricular function, ventricular volume, and interventricular septal position after VAD placement.


REFERENCES


Simpson KE, Kirklin JK, Cantor RS et al. Right heart failure with left ventricular assist device implantation in children: An analysis of the Pedimacs registry database. J Heart Lung Transplant. 2020;39(3):231-240. doi: 10.1016/j.healun.2019.11.012.


Law SP, Morales DLS, Si MS, et al. Right heart failure considerations in pediatric ventricular assist devices. Pediatr Transplant. 2021;25(3):e13990. doi:10.1111/petr.13990


Horton S, Skiner A, Bacigalupo A, Adachi I, Stayer S, Motta P. Mechanical Circulatory Support. In: Andropoulos D, Mossad E, Gottlieb E, eds. Anesthesia for Congenital Heart Disease. 4th Edition. Hoboken, New Jersey: John Wiley & Sons, Inc.; 2023: 996-1025.

Poll of the Month

May 2025
At your institution, do you routinely send a TEG/ROTEM during the rewarming phase of cardiopulmonary bypass?
View Results
Total Answers 130
Total Votes 130

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy